SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
about
Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyImpact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice.SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway.SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
P2860
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@en
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@nl
type
label
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@en
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@nl
prefLabel
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@en
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@nl
P2093
P2860
P356
P1476
SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.
@en
P2093
Ayesha Ghayur
Guang Chen
Joan C Krepinsky
Lalita Uttarwar
Peter Margetts
Renzhong Li
Richard vanKrieken
P2860
P304
P356
10.1093/JMCB/MJU041
P577
2014-10-26T00:00:00Z